|
|
|
|
|
|
|
|
|
21.10.26 - 18:33
|
William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--William Blair today announced that Alethia Young has initiated coverage of 13 biotechnology companies, marking the next step in the firm's continued expansion of its biotech offering.
Young joined William Blair in May 2026 as part of a broader investment in the firm's equities platform. With 25 years of experience across biotechnology and healthcare, she brings a perspective shaped by roles on both Wall Street and within the industry, most recently as chief financial officer of Bicycle Therapeutics.
Young's initial coverage spans 13 biotechnology companies: Ascentage Pharma Group (AAPG), Cytokinetics (CYTK), Edgewise Therapeutics (EWTX), Faeth Therapeutics (FTH), IDEAYA Biosciences (IDYA), Immunome (IMNM), Kardigan (KARD), Palvella Therapeutics (PVLA), Arcus Biosciences (RCUS), Revolution Medicines (RVMD), Rhythm Pharmaceuticals (RYTM), Tango Therapeutics (TNGX), and Wave Life Sciences (WVE).
Her inaugural research focuses on several themes shaping opportunities across biotech...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.10.26 - 13:33
|
Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference (GlobeNewswire EN)
|
|
|
WAYNE, Pa., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for serious, rare skin diseases and vascular anomalies for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced that members of its management team will participate in a fireside chat at the Chardan 10th Annual Healthcare Conference on Tuesday, October 20, 2026, at 1:45 p.m. ET....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
